Skip to content
DataLookout
Menu

Beijing Gene Key Life Technology Co., Ltd clinical trial pipeline

Get alerts when Beijing Gene Key Life Technology Co., Ltd's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  1. Notable: GKL-006 Injection · Advanced Pancreatic Cancer Enrollment reopened Beijing Gene Key Life Technology Co., LtdPhase 1/2 NCT07777211
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-11-04 NCT07915544 A Study of GKL-006Allo Injection in Patients With Ankylosing Spondylitis Phase 1 Not Yet Recruiting

Active trials by phase

Phase 1
3
Phase 1/2
2
Phase 2
1

Disease areas by active trials

Get alerts when Beijing Gene Key Life Technology Co., Ltd's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free